KEPIVANCE
KEPIVANCE
Discontinued
DIN Number
02274221
Drug Class
Human
Market Date
Mar 14, 2006
Company
HC
Swedish Orphan Biovitrum AB (Publ)
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02274221
AIG Number0151563001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
V03AF08 PALIFERMIN
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification84:16.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
PALIFERMINActive
Strength: 6.25 MG / VIAL
Monograph: PALIFERMIN